Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT02523222

Dextrose Gel Does Not Prevent Neonatal Hypoglycemia

Prophylactic Dextrose Gel Does Not Prevent Neonatal Hypoglycemia: a Quasi-experimental Pilot Study

Sponsor: Baylor College of Medicine

Conditions Complication of Prematurity Fetal Macrosomia Hypoglycemia Infant, Small for Gestational Age Intrauterine Growth Restriction Neonatal Hypoglycemia Premature Birth of Newborn

Interventions 40% Dextrose gel

Updated 6 times since 2017 Last updated: Jan 6, 2025 Started: Jul 1, 2016 Primary completion: Mar 1, 2018 Completion: Jul 30, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2/PHASE3 trial investigates Complication of Prematurity and Fetal Macrosomia and is currently completed. Baylor College of Medicine leads this study, which shows 6 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Feb 2025 — Present [monthly]

Completed PHASE2/PHASE3

Phase: NA → PHASE2/PHASE3
Sep 2024 — Feb 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jul 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Baylor College of Medicine

Data source: Baylor College of Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Houston, United States